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A b s t r a c t  
To develop and validate simple, rapid, economic and accurate spectrophotometric methods for the 
estimation of the Alprazolam and Propranolol which can be applied successfully for the analysis of 
both the drugs in pure as well as in their combined dosage form.  
A double-beam Shimadzu UV-Visible spectrophotometer, 1800, with a pair of 1cm matched quartz 
cells was used to measure the absorbance of the solutions in both developed methods viz. 
simultaneous equation method and absorption ratio method. 0.1N HCl was selected as solvent for 
the preparation of solutions. After scanning 10μg/ml solution of each drug separately in the range of 
200-400 nm, wavelength of maximum absorption of ALP (262.5 nm) and PROP (288.5 nm) were 
selected for simultaneous equation method and isobestic point (283 nm) and absorption maxima of 
ALP (262.5 nm) were selected for absorption ratio method. The methods were validated statistically 
as per ICH guidelines. 
Linearity ranges from 5-25 μg/ml for both drugs. %RSD calculated was less than equal to 2 which 
indicates accuracy and reproducibility of the method. Recovery studies indicate that these drugs 
could be quantified simultaneously without interference of the excipients present in formulation. 
The developed UV spectroscopic methods are simple, precise, less time consuming, economical 
and accurate and thus are suitable for the analysis of ALP and PROP in combined dosage form. 
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Introduction 
Alprazolam (ALP), chemically 8-chloro-1-methyl-6-phenyl-4H-
[1,2,4]triazolo[4,3-a][1,4]benzodiazepine (Fig 1) is a potent short-
acting drug of the benzodiazepine class which acts by enhancing 
the effects of a neurotransmitter GABA in the body and thus 
primarily used in the treatment of moderate to severe anxiety 
disorders and panic attacks and also possesses anxiolytic, 
sedative, hypnotic, anticonvulsant and amnesic properties[1-4] 
whereas Propranolol (PROP), chemically (RS)-1-
(isopropylamino)-3-(1-naphthyloxy) propan-2-ol (Fig 2) is a non-
selective beta blocker and is mainly used in the treatment of 
hypertension by blocking the action of epinephrine and 
norepinephrine on both β1- and β2- adrenergic receptors and also 
used in the management of hypertension, angina pectoris, 
myocardial infarction, migraine, glaucoma etc. [5-7] 
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Fig 1: Chemical structure of Alprazolam 
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Fig 2: Chemical structure of Propranolol  
ISSN: 0975-0215 
 
  
This work is licensed under a Creative Commons Attribution 3.0 License.  
Chaudhary et al. International Journal of Drug Delivery 4 (3) 310-315 [2012] 
 
PAGE | 311 | 
 
 
Literature survey revealed that ALP has been estimated with other 
drugs using UV [8], HPLC [9-11], LCMS [12-13], flourimetry [14] 
and HPTLC [9-10].  Similarly PROP has been determined along 
with other drugs by UV [15-16], HPLC [17-20] and HPTLC [21]. 
Since, no spectrophotometric method has been reported yet for 
simultaneous estimation of ALP and PROP, so the present study 
is focused on a successful attempt to estimate ALP and PROP 
using more economical UV spectrophotometric method..  
Materials and Methods 
Pure standards of ALP and PROP were obtained as gift sample 
and their marketed combination (Ambulax-M) was purchased from 
the market. 0.1 N HCl of analytical grade was used as the solvent. 
A  double-beam  Shimadzu  UV-visible  spectrophotometer,  1800  
with  a  pair of  1 cm  matched  quartz  cells  were  used  to  
measure  the  absorbance  of  the  solutions.  
Preparation of Standard Stock Solutions 
Accurately weighed 10 mg of ALP and PROP were dissolved 
separately in small amount of 0.1N HCl in 10ml volumetric flask. 
The drug was dissolved with sonication and the final volume was 
adjusted with 0.1N HCl up to the mark to get a solution of 1000 
µg/ml each and then further diluted to get 10µg/ml. 
Determination of Absorption maxima 
The prepared standard solutions (10µg/ml) were scanned in the 
UV‐VIS spectrophotometer in the wavelength range of 200‐400 
nm and an overlain spectrum was recorded (Fig.3). Using the 
overlain spectra, the wavelength maxima of both drugs, i.e. 262.5 
nm (λ1 for ALP) and 288.5 nm (λ2 for PROP), were selected as 
two sampling wavelengths for simultaneous equation method and 
283.0 nm (isobestic point) was selected for absorbance ratio 
method The prepared stock solutions were then diluted to get 
solutions of 5-25 µg/ml for both the drugs. The absorbance  of  
these  solutions  were  measured  at  the  selected  wavelengths  
and absorptivities  were  determined (Table 1).  
 
Table 1: Absorptivity of ALP and PROP at 262.5 nm, 288.5 nm 
and 283nm respectively. 
 
Components Absorptivity 
at 262.5 nm 
Absorptivity 
at 288.5 nm 
Absorptivity 
at 283 nm 
ALP 40 19.2 22.85 
PROP 14.688 34.118 20.06 
Method A: Vierodt’s Method of Simultaneous Equations 
This method is based on absorption of drugs at the wavelength 
maximum of the other. It employs solving of simultaneous 
equations using Cramer’s rule and matrices. The concentrations 
of the drugs were calculated from the following simultaneous 
equations: 
Cx =    A1 ay2 – A2 ay1 
             ax1 ay2 – ax2 ay1 .................Eq. 1 
Cy =    A1 ax2 – A2 ax1 
             ay1 ax2 – ay2 ax1 .................Eq. 2 
Where,  A1  and  A2  are  absorbance  of  mixture  at  262.5  nm  
and  288.5  nm  respectively, ax1  and  ax2  are  absorptivities  of  
ALP  at  λ1  and  λ2  respectively  and  ay1  and  ay2  are 
absorptivities  of  PROP  at  λ1  and  λ2  respectively.  Cx  and  Cy  
are  the  concentrations  of PROP  and  ALP  respectively. 
Method B: The Graphical Absorption Ratio Method (Q-Analysis) 
This method is modification of simultaneous equation method 
which is based on measurement of absorbance at two 
wavelengths, one being the isoabsorptive point (298nm) and 
second be the λmax of one of the component (288nm). The 
concentrations of drugs were determined by using the following 
equations, 
Cx = (Qm - Qy) A1/ (Qx - Qy)/a------------ Eq. 3 
Cy = (Qm - Qx) A1/ (Qy - Qx)/a2………. Eq. 4 
Where Cx and Cy are the concentration of ALP and PROP 
respectively, A1 is the absorbance of sample and a1 and a2 are 
absorptivities of ALP and PROP respectively at iso-absorptive 
wavelength,  
Qm is absorbance of sample at λmax/ absorbance of sample at 
iso-absorptive wavelength 
Qx is absorptivity of ALP at λmax / absorptivity of ALP at iso-
absorptive wavelength 
Qy is absorptivity of PROP at λmax / absorptivity of PROP at iso-
absorptive wavelength 
 
Application Of The Developed Method On Tablet 
Dosage Form 
 
Twenty tablets (Ambulax-M) were weighed, crushed and an 
accurately weighed sample equivalent to 10mg of PROP was 
taken in which 9.75 mg of pure ALP was added by standard 
addition method in order to bring both drugs in 1:1 ratio. The drug 
powder was dissolved in 0.1N HCl with sonication, filtered through 
Whatman filter paper and then volume was made up to 10 ml with 
0.1N HCl to get stock solution of 1000 µg/ml of each drug and 
then further diluted to get 10µg/ml. All determinations were carried 
out three times at selected wavelengths and then the 
concentration of both the drugs was calculated using Equation 1 
and 2 in Method I and Equations 3 and 4 in Method II and the 
results are given in Table 2. 
Analytical Method Validation 
The developed method was validated according to the ICH 
guidelines [22-23] using following parameters. 
Linearity 
The linearity of this method was evaluated by linear regression 
analysis and both the drugs shows linearity in the concentration 
Chaudhary et al. International Journal of Drug Delivery 4 (3) 310-315 [2012] 
 
PAGE | 312 | 
 
 
range of 5-25 μg/ml. Linearity graph is shown in Fig. 4 and 
regression coefficients are reported in Table III. 
Limit of detection and quantification 
Limit of detection (LOD) and Limit of quantification (LOQ) were 
calculated as 3.3σ/S and 10σ/S, respectively, where S is the slope 
of calibration curve and ‘SD’ is standard deviation of y-intercept of 
regression equation.(Table 3).  
Inter-day and Intra-day Precision 
Precision was studied by measuring absorbance of three replicate 
samples of 10 μg/ml concentration in triplicate on same day 
(Intra-day precision) and on three consecutive days (Inter-day 
precision). The results are shown in Table 4 
Accuracy (% Recovery) 
The recovery studies were done by spiking the sample of known 
concentration (10 μg/ml) with known concentrations of the pure 
samples (80%, 100% and 120%) and then reanalyzed using the 
proposed methods. Percentage recovery was calculated using the 
equations for both the methods (Table 5). 
Results and Discussion 
The methods discussed in the present work provide a convenient 
way to estimate ALP and PROP in pharmaceutical dosage form. 
Linearity was analyzed on selected wavelengths (262.5 nm (λ1Alp) 
and 288.5 nm (λ2Prop) and 283nm (isobestic point) and was found 
to be in concentration range 5-25µg/ml for both drugs (Table 3). 
Regression analysis was done and higher values of correlation 
coefficient (r2) indicate good linearity for both the drugs (Fig. 4).   
The results of limit of detection (LOD) and limit of quantification 
(LOQ) shows the sensitivity of both the methods.  
The precision of the proposed methods was determined by inter- 
and intra-day precision methods and the results are found to be 
97-99.43% and 97.07-99.10% in case of inter-day precision and 
intra-day precision respectively (Table 4). 
The amount of ALP and PROP in marketed formulation was 
determined by the proposed methods and ranges between 97.2-
98.73% for simultaneous equation method and 98.7-99.56% for 
absorption ratio method (Table 2). % RSD calculated was less 
than 2 which indicates the accuracy and reproducibility of the 
method  
The proposed method was validated according to the ICH 
guidelines. Low values of standard deviation show accuracy, 
repeatability and reproducibility of both the methods. The 
accuracy of the method was proved by performing recovery 
studies in which the results ranges from 98.56-100.36% in 
simultaneous equation method and from 99.7-100.16% in case of 
absorption ratio method (Table 5) which indicates that these drugs 
could be quantified simultaneously without the interference of the 
excipients present in the formulation. 
Statistical analysis and drug recovery data showed that both 
methods are simple, rapid, economical, sensitive, precise and 
accurate and since no spectroscopic method has been reported 
therefore the proposed methods are suitable for the simultaneous 
determination of these drugs in pharmaceutical formulations 
therefore, the above method can be successfully applied in 
simultaneous estimation of ALP and PROP in marketed 
formulations with virtually no interference of the additives. 
 
Table 2: Result analysis of the tablet mixture 
Drug  Label claim 
(mg/ tab.) 
Method 1 Method 2 
Amount found (mg) %Drug found ±SD Amount found (mg) %Drug found ±SD 
ALP 0.25 0.243 97.2±0.489 0.246 98.7±0.637 
PROP 10 9.873 98.73±0.543 9.956 99.56±0.946 
Values expressed in mean± SD (n=3) 
Table 3: Optical characteristics 
Parameters 262.5 nm 288.5 nm 283 nm 
ALP PROP ALP PROP ALP PROP 
Beer’s law limit 
(μg/ml) 
5-25 5-25 5-25 5-25 5-25 5-25 
Regression equation Y= m X + c 
Slope (m) 0.040 0.014 0.018 0.030 0.023 0.02 
Intercept (c) -0.007 0.004 0.005 0.017 -0.012 -0.001 
Correlation coefficient (R2) 0.999 0.998 0.999 0.998 0.999 0.999 
Standard deviation SD 0.0005 0.0004 0.0003 0.0003 0.001 0.0005 
Limit of detection (μg/ml) 0.041 0.094 0.055 0.033 0.143 0.0825 
Limit of quantification (μg/ml) 0.125 0.285 0.166 0.1 0.434 0.25 
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Table 4: Intra-day precision and accuracy of ALP and PROP 
 METHOD-I  METHOD-II  
 Intra day  Inter day  Intra day  Inter day  
ALP PROP  ALP PROP  ALP PROP  ALP PROP  
Mean%  
±  
S.D.  
97.07% 
± 
0.266 
98.52 
± 
0.302  
97%  
± 
0.251  
97% 
 ± 
0.0481  
98.66%  
± 
1.268  
99.1% ± 
1.267  
99.43% ± 
0.594  
98.73% ± 
0.558  
Precision, %RSD  0.274  0.307 0.259  0.496 1.285 1.279 0.597  0.565  
Values expressed mean± SD (n=3) 
 
Table 5: Recovery studies 
Drug Amount 
present 
(μg/ml) 
Amount of standard drug 
added (μg/ml) 
Method I Method II 
Amount recovered 
(μg/ml) 
%Recovery ± SD % RSD Amount 
recovered 
(μg/ml) 
% Recovery 
± SD 
% RSD 
 
ALP 
10 80%(8μg/ml) 18.01 100.06 ±0.735 0.735 18.06 100.33 ±0.564 0.562 
10 100%(10μg/ml) 19.85 99.25  ± 1.268 1.278 20.02 100.10±0.579 0.578 
10 120%(12μg/ml) 22.04 100.18 ±0.510 0.509 21.96 99.81±0.588 0.589 
 
PROP 
10 80%(8μg/ml) 17.96 99.77  ± 1.033 1.035 18.01 100.06±0.589 0.589 
10 100%(10μg/ml) 19.98 99.90  ± 1.027 1.028 19.97 99.85±1.247 1.249 
10 120%(12μg/ml) 21.98 99.91  ± 0.969 0.97 22.01 100.04±0.999 0.999 
Values expressed mean± SD (n=3) 
 
Figure 3: Overlain spectra showing absorption maxima of ALP at 262.5 nm and PROP at 288.5 nm & Isobestic point at 283 nm. 
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Figure 4: Linearity graphs of ALP and PROP at 262.5 (λmax of ALP), 288.5 (λmax of PROP) and 283 nm (Isobestic point).  
 
Conclusion 
These results show that the proposed UV spectroscopic methods 
are simple, precise, economic, rapid and accurate therefore they 
are suitable for the analysis of ALP and PROP in the bulk and 
tablet dosage form without the interference of excipients.  
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